We are live on
!
Find out more
HCG
Haven Capital Group Portfolio holdings
AUM
$125M
1-Year Est. Return
30.81%
This Fund
S&P 500
This Quarter
Est. Return
+20.51%
1 Year Est. Return
+30.81%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$125M
AUM Growth
+$16.8M
(+16%)
Cap. Flow
+$532K
Cap. Flow
% of AUM
0.43%
Top 10 Holdings %
Top 10 Hldgs %
71.51%
Holding
40
New
3
Increased
12
Reduced
9
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$1.18M |
| 2 |
Microsoft
MSFT
|
+$666K |
| 3 |
Meta Platforms (Facebook)
META
|
+$530K |
| 4 |
CRWV
CoreWeave
CRWV
|
+$263K |
| 5 |
Emerson Electric
EMR
|
+$214K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.27M |
| 2 |
TransDigm Group
TDG
|
+$815K |
| 3 |
Idexx Laboratories
IDXX
|
+$362K |
| 4 |
Verizon
VZ
|
+$234K |
| 5 |
Iovance Biotherapeutics
IOVA
|
+$208K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 55.58% |
| 2 | Healthcare | 16.45% |
| 3 | Communication Services | 8.52% |
| 4 | Consumer Discretionary | 7.87% |
| 5 | Industrials | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Equinix
EQIX
$107B
| $507K | 0.41% |
486
| – | – |
|
27
Public Service Enterprise Group
PEG
$37.2B
| $506K | 0.41% |
6,231
| – | – |
|
28
Skyworks Solutions
SWKS
$10.2B
| $377K | 0.3% |
5,564
-19
| -0.3% | -$1.29K |
|
29
Zebra Technologies
ZBRA
$17.1B
| $366K | 0.29% |
1,390
| – | – |
|
30
Gilead Sciences
GILD
$178B
| $345K | 0.28% |
2,730
| – | – |
|
31
Bristol-Myers Squibb
BMY
$134B
| $343K | 0.28% |
5,958
| – | – |
|
32
Eli Lilly
LLY
$1.11T
| $297K | 0.24% |
248
| – | – |
|
33
Expeditors International
EXPD
$24.2B
| $272K | 0.22% |
1,670
| – | – |
|
34
Applied Materials
AMAT
$394B
| $260K | 0.21% |
+360
| New | +$166K |
|
|
CRWV
35
CoreWeave
CRWV
$49.5B
| $242K | 0.19% |
+2,436
| New | +$263K |
|
|
36
Emerson Electric
EMR
$86.3B
| $217K | 0.17% |
+1,517
| New | +$214K |
|
37
Southern Company
SO
$105B
| $202K | 0.16% |
2,113
| – | – |
|
|
38
Iovance Biotherapeutics
IOVA
$4.07B
| – | – |
-59,143
| Closed | -$208K |
|
|
39
TransDigm Group
TDG
$65.2B
| – | – |
-703
| Closed | -$815K |
|
|
40
Verizon
VZ
$204B
| – | – |
-4,653
| Closed | -$234K |
|
Similar funds
EIP
KSB
BHPW
PWM
CHWM
KWM
CFM
BVP
Haven Capital Group's Q2 2026 Portfolio in Review
As of Q2 2026, Haven Capital Group held 40 positions worth $125M, up 16% from $108M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Haven Capital Group's Q2 2026 filing shows 3 new, 12 increased, 9 reduced and 3 closed positions. Its largest new stake was CoreWeave: 2,436 shares worth $242K. The largest sale was Broadcom, an estimated $1.27M.
By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 53% a quarter earlier, followed by Healthcare and Communication Services.
- Haven Capital Group's largest Q2 2026 buy was CoreWeave: 2,436 shares worth $242K.
- Haven Capital Group added most to Adobe in Q2 2026, an estimated $1.18M increase.
- Haven Capital Group's biggest Q2 2026 reduction was Broadcom, cutting an estimated $1.27M.
- Haven Capital Group fully exited TransDigm Group in Q2 2026, selling an estimated $815K.
- Haven Capital Group's ten largest holdings make up 72% of its $125M portfolio in Q2 2026.
- Haven Capital Group opened 3 new positions and closed 3 in Q2 2026.
- Haven Capital Group's portfolio value rose 16% quarter-over-quarter to $125M.
Based on Haven Capital Group's 13F filing for Q2 2026, filed 10 Jul 2026.